Boehringer Ingelheim Fremont, Inc.

Form 483FOIA Uncovered

Fremont, California, United StatesFEI 3005925062Issued November 04, 2022

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3005925062.

Observations1

Issue DateNovember 04, 2022

StatusNo Warning Letter

Related Inspections5

Establishment Details

Firm: Boehringer Ingelheim Fremont, Inc.
Location: Fremont, California, United States
FEI Number: 3005925062
Product Type: Drugs
Issue Date: November 04, 2022
Country: United States

Inspection History, 2010 to 2022

NAI1

VAI4

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Boehringer Ingelheim Fremont, Inc. FDA Form 483, Fremont, California, November 4, 2022